Windtree Therapeutics Inc (WINT) concluded trading on Wednesday at a closing price of $0.77, with 78.17 million shares of worth about $60.19 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -95.03% during that period and on July 02, 2025 the price saw a gain of about 40.00%. Currently the company’s common shares owned by public are about 3.56M shares, out of which, 0.75M shares are available for trading.
Stock saw a price change of 108.11% in past 5 days and over the past one month there was a price change of 2.69%. Year-to-date (YTD), WINT shares are showing a performance of -99.52% which decreased to -95.59% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.36 but also hit the highest price of $737.43 during that period. The average intraday trading volume for Windtree Therapeutics Inc shares is 2.55 million. The stock is currently trading 36.32% above its 20-day simple moving average (SMA20), while that difference is down -0.81% for SMA50 and it goes to -96.40% lower than SMA200.
Windtree Therapeutics Inc (NASDAQ: WINT) currently have 3.56M outstanding shares and institutions hold larger chunk of about 6.04% of that.
The stock has a current market capitalization of $2.81M and its 3Y-monthly beta is at 0.58. It has posted earnings per share of -$1261.32 in the same period. It has Quick Ratio of 0.25 while making debt-to-equity ratio of 0.15. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for WINT, volatility over the week remained 28.20% while standing at 18.35% over the month.
Digging deeper we find that several firms have released their research notes about the support levels of the stock. Most recent of them is a note released by Ladenburg Thalmann on June 26, 2020 offering a Buy rating for the stock and assigned a target price of $12.25 to it.
